Company Filing History:
Years Active: 2013
Title: Innovations by Andreas Rolfs in Cancer Treatment
Introduction
Andreas Rolfs is a notable inventor based in Eisenach, Germany. He has made significant contributions to the field of cancer treatment through his innovative work on nucleosides. His research focuses on developing methods to suppress or reduce the development of resistance in cytostatic therapy.
Latest Patents
Andreas Rolfs holds a patent for "Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy." This invention relates to special nucleosides, including a nucleoside of the formula I, wherein R-Rare is described in detail. The patent also covers drugs that contain these nucleosides and their use in methods aimed at suppressing or reducing the formation of resistance during cytostatic treatment of cancer patients. He has 1 patent to his name.
Career Highlights
Andreas Rolfs is associated with Resprotect GmbH, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in the fight against cancer.
Collaborations
He has collaborated with notable colleagues such as Rudolf Fahrig and Dieter Lohmann, contributing to advancements in cancer treatment methodologies.
Conclusion
Andreas Rolfs' work exemplifies the impact of innovation in medical science, particularly in enhancing cancer treatment strategies. His contributions are vital in the ongoing battle against cancer resistance.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.